2018
DOI: 10.1016/s0735-1097(18)30933-1
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Ivabradine Administration on the Night Drop of Heart Rate in Patients With Inappropriate Sinus Tachycardia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
3
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 0 publications
2
3
0
Order By: Relevance
“…In other words, the effect of ivabradine on heart rate showed a circadian rhythm and was greater when the subjects were awake. This is consistent with the work on the mice (Figure 5C,D) 54 . However, it is known that cardiac-specific knockout of Bmal1 46 or cardiac-specific expression of a dominant negative Clock mutant 56 does not abolish the circadian rhythm in heart rate in vivo (although it does reduce it).…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…In other words, the effect of ivabradine on heart rate showed a circadian rhythm and was greater when the subjects were awake. This is consistent with the work on the mice (Figure 5C,D) 54 . However, it is known that cardiac-specific knockout of Bmal1 46 or cardiac-specific expression of a dominant negative Clock mutant 56 does not abolish the circadian rhythm in heart rate in vivo (although it does reduce it).…”
Section: Discussionsupporting
confidence: 93%
“…Furthermore, block of HCN4 and I f by ivabradine had a bigger effect on heart rate during the awake period and abolished the circadian rhythm in heart rate in vivo in the mouse (Figure 5C). Data consistent with this have been obtained by Ptaszynski et al 54 and Grigoryan et al 55 who studied the effect of ivabradine on the heart rate of patients either with inappropriate sinus node tachycardia or ischaemic heart disease and heart failure; whereas ivabradine caused a large decrease in heart rate during the day, it caused little decrease at night. In other words, the effect of ivabradine on heart rate showed a circadian rhythm and was greater when the subjects were awake.…”
Section: Discussionsupporting
confidence: 79%
“…The circadian variations of these humoral factors appear to be under the control of the SCN which uses vasoactive intestinal peptide (VIP) to directly and indirectly modulate the release of adrenocorticotropic hormone (ACTH; Buijs et al, 2003 ; Boudreau et al, 2012 ; Morris et al, 2012 ). On the other hand, previous studies have concluded that circadian HR fluctuations arise from daily changes in the intrinsic properties of the SA node (i.e., local circadian cardiac clock; Wang et al, 2021 ), arising from changes in the expression of HCN4-based pace-maker channels ( Oosting et al, 1997 ; Ptaszynski et al, 2018 ; D'Souza et al, 2020 ) or other channels including Kv4.2 ( Yamashita et al, 2003 ) and Kv1.5 ( Durgan et al, 2005 ). While these variations can clearly contribute to the daily HR variations seen in the absence of ANS activity, our studies establish that the ANS plays a necessary and dominant role in controlling basal circadian daily HR fluctuations in anesthetized mice.…”
Section: Discussionmentioning
confidence: 97%
“…Data consistent with the time-of-day dependence of HCN4 block have been obtained from patients: in patients with inappropriate sinus tachycardia or ischemic heart disease and heart failure, ivabradine causes a large decrease in heart rate during the day and a slight decrease at night. 25,26 Nevertheless, I f may not be the only mechanism involved: there was a daynight difference in calcium/calmodulin dependent protein kinase II delta (Camk2d/CaMKIId) expression and various K 1 channels, particularly ether-a-go-go related gene (ERG; Kcnh2) (Figure 2A). Further study is warranted on the relative importance of these alterations in controlling SN pacemaking.…”
Section: Discussionmentioning
confidence: 99%